Expression of Endothelial Differemtiation Gene Receptors in Human Pancreatic Cancer

GONG Yong-ling,WANG Wei-dong,WANG Shao-kai,Tao Chen-jie,YANG Jing-song,TIAN Ren,CHEN Jing-fei,WANG Shu-kui,L(U) Guang-mei
DOI: https://doi.org/10.3760/cma.j.issn.1674-1935.2011.06.005
2011-01-01
Abstract:Objective To evaluate the expression of endothelial differentiation gene/lysophosphatidic acid (LPA) receptors (Edg/LPA) and its clinical significance in human pancreatic cancer.Methods Fifty cases of pancreatic cancer and adjacent normal tissues were collected,and Real-time PCR,Western blot and immunohistochemistry was used to determine the expression of Edg-2/LPA1,Edg-4/LPA2 and Edg-7/LPA3 receptors mRNA and protein,and its relationship with clinicopathological parameters was analyzed.Results The expressions of Edg-2/LPA1,Edg-4/LPA2,Edg-7/LPA3 receptor mRNA were (0.142 ± 0.042 ) %,(0.471 ±0.064)%,(0.231 ±0.043)% in pancreatic cancer,and the corresponding values were (0.132 ±0.029)%,(0.027 ±0.015)%,(0.163 ±0.046)% in adjacent normal tissues.The expressions of Edg-4/LPA2 receptor mRNA in pancreatic cancer were significantly lower than that in adjacent normal tissues ( P <0.05 ).The expressions of Edg-4/LPA2 receptor protein in pancreatic cancer were significantly lower than that in adjacent normal tissues ( P < 0.05 ).The expressions of three types of Edg /LPA receptor mRNA in pancreatic cancer were parallel to serum CA19-9 levels.The expressions of Edg-4/LPA2 receptor mRNA were associated with tumor size,differentiation degree,and invasive ability and metastasis.While the expressions of Edg-2/LPA1,Edg-7/LPA3 receptor mRNA was associated with invasive ability and metastasis only.Conclusions Edg-4/LPA2 receptor is highly expressed in pancreatic cancer,which suggesting the malignant biological behavior of pancreatic cancer.
What problem does this paper attempt to address?